Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1Phase 2 1

Status

Completed 4Unknown 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 2Head & Neck 1

Conditions

Breast Neoplasms 2Stage I or II Micro-invasive Oral Cancer 1Head and Neck Neoplasms 1Dermatitis 1

Interventions

Cyclophosphamide 1488Cisplatin 1410Paclitaxel 1316Radiotherapy 1259Carboplatin 1247Gemcitabine 1214Docetaxel 1110Bevacizumab 1029Fluorouracil 894Doxorubicin 786Dexamethasone 746Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 673Etoposide 673Irinotecan 634Filgrastim 621Cytarabine 584Leucovorin 578Nivolumab 557Vincristine 510Prednisone 474Cetuximab 464Bortezomib 457Erlotinib Hydrochloride 456Trastuzumab 448Methotrexate 437Lenalidomide 426Pemetrexed 419

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Interventional × Reference Standards × Clear all
NCT04603911 2025-01-10

RCT Comparing ESPB Solutions in Breast Surgery

Tufts Medical Center

Phase 2 Completed
75 enrolled
Breast

Breast Neoplasms

NCT05982197 2023-08-08

Curcumin Gel On Radiation Induced Oral Mucositis

University of Baghdad

Phase NA Completed
40 enrolled
Head & Neck

Head and Neck Neoplasms

NCT05417529 2022-06-14

PMLOS

Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari

Phase NA Completed
60 enrolled

Stage I or II Micro-invasive Oral Cancer

NCT01762020 2017-03-08

Barrier Film vs. Standard Skin Care in Preventing Dermatitis in Women With Breast Cancer Receiving Radiation

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 3 Completed
56 enrolled
Breast

Breast Neoplasms, Dermatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡